Blog Archive

Search This Blog

Monday, September 25, 2017

Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esophageal Squamous Cell Carcinoma- Part 1 (HNSCC)]

Conditions:   HNSCC;   Head and Neck Neoplasms
Interventions:   Drug: BYL719;   Drug: Poziotinib;   Drug: Nintedanib;   Drug: Abemaciclib;   Drug: Durvalumab,Tremelimumab
Sponsors:   Seoul National University Hospital;   Korean Cancer Study Group;   Chungnam National University Hospital
Recruiting - verified September 2017

from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2fLM0J2

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Blog Archive

Pages

   International Journal of Environmental Research and Public Health IJERPH, Vol. 17, Pages 6976: Overcoming Barriers to Agriculture Green T...